Published in Semin Respir Crit Care Med on April 01, 2005
Neutrophil elastase in cyclic and severe congenital neutropenia. Blood (2006) 1.74
Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol Cells (2013) 1.24
CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. J Clin Immunol (2010) 1.16
Vitamin D deficiency and chronic lung disease. Can Respir J (2009) 1.11
The emerging importance of autophagy in pulmonary diseases. Chest (2012) 1.03
New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy. Dermatology (2009) 1.00
Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations. J Inherit Metab Dis (2008) 0.95
Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils. J Immunol (2012) 0.93
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency. Biologics (2009) 0.91
Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency. BMC Pulm Med (2007) 0.84
Proteome of Rhipicephalus sanguineus tick saliva induced by the secretagogues pilocarpine and dopamine. Ticks Tick Borne Dis (2013) 0.83
Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy. Hum Gene Ther (2015) 0.83
Genotypes and serum concentrations of human alpha-1-antitrypsin "P" protein variants in a clinical population. J Clin Pathol (2007) 0.79
Leptin Resistance: A Possible Interface Between Obesity and Pulmonary-Related Disorders. Int J Endocrinol Metab (2016) 0.75
Context-Specific and Immune Cell-Dependent Antitumor Activities of α1-Antitrypsin. Front Immunol (2016) 0.75
Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency. PLoS One (2015) 0.75
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94
Counterpoint: Are the CHEST guidelines global in coverage? No. Chest (2015) 2.88
Diffuse alveolar hemorrhage: diagnosing it and finding the cause. Cleve Clin J Med (2008) 2.62
Just imagine: new paradigms for medical education. Acad Med (2013) 2.14
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med (2009) 1.70
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note. Chest (2008) 1.60
The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the national registry for individuals with Severe Deficiency of Alpha-1 Antitrypsin. Hum Pathol (2004) 1.55
A review of physician turnover: rates, causes, and consequences. Am J Med Qual (2004) 1.49
Exploring leadership competencies in established and aspiring physician leaders: an interview-based study. J Gen Intern Med (2008) 1.48
Laboratory evaluation of the Vortran Automatic Resuscitator Model RTM. Respir Care (2007) 1.41
A comparison of respiratory care workload with 2 different nebulizers. Respir Care (2009) 1.39
Acute eosinophilic pneumonia complicating Coccidioides immitis pneumonia: a case report and literature review. Respiration (2007) 1.39
Respiratory care work assignment based on work rate instead of work load. Respir Care (2011) 1.39
Use of noninvasive positive-pressure ventilation on the regular hospital ward: experience and correlates of success. Respir Care (2006) 1.39
Impact of a program to provide patients with comparative information about providers of durable medical equipment for home respiratory care. Respir Care (2004) 1.39
Changing patterns of inpatient respiratory care services over a decade at the Cleveland Clinic: challenges posed and proposed responses. Respir Care (2005) 1.38
A middle-aged woman with chronic liver disease and shortness of breath. Cleve Clin J Med (2006) 1.38
Severe agitation among ventilated medical intensive care unit patients: frequency, characteristics and outcomes. Intensive Care Med (2004) 1.32
Perspective: Can emotional intelligence training serve as an alternative approach to teaching professionalism to residents? Acad Med (2011) 1.30
Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest (2004) 1.16
Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Thorax (2007) 1.12
Detection of upper airway obstruction with spirometry results and the flow-volume loop: a comparison of quantitative and visual inspection criteria. Respir Care (2009) 1.10
Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am J Cardiol (2009) 1.09
Pulmonary venous thrombosis and infarction complicating pulmonary venous stenosis following radiofrequency ablation. Respir Care (2004) 1.09
Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest (2003) 1.09
Leadership and organization development in health-care: lessons from the Cleveland Clinic. Adv Health Care Manag (2011) 1.09
IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol (2007) 1.08
The influence of mentorship and role modeling on developing physician-leaders: views of aspiring and established physician-leaders. J Gen Intern Med (2009) 1.08
Emphysema in nonsmokers: alpha 1-antitrypsin deficiency and other causes. Cleve Clin J Med (2002) 0.99
The utility of spirometry in diagnosing pulmonary restriction. Lung (2007) 0.98
Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel. Respir Care (2004) 0.95
Augmentation therapy in alpha-1 antitrypsin deficiency. Expert Opin Biol Ther (2008) 0.91
Commentary: Recommendations and remaining questions for health care leadership training programs. Acad Med (2013) 0.91
Low levels of nitric oxide and carbon monoxide in alpha 1-antitrypsin deficiency. J Appl Physiol (1985) (2002) 0.90
Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature. Respiration (2007) 0.90
Smoking cessation. Respir Care (2003) 0.89
Pulmonary hypertension after liver transplantation in patients with antecedent hepatopulmonary syndrome: a report of 2 cases and review of the literature. Liver Transpl (2006) 0.89
Transudative chylothorax associated with sclerosing mesenteritis. Respir Care (2010) 0.88
Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency. Respir Res (2012) 0.88
A review of alpha-1 antitrypsin deficiency. COPD (2005) 0.88
Right-to-left anatomic shunt associated with a persistent left superior vena cava: the importance of injection site in demonstrating the shunt. Chest (2009) 0.87
Caring for VIPs: nine principles. Cleve Clin J Med (2011) 0.87
Transudative chylothorax: report of two cases and review of the literature. Lung (2005) 0.87
A systematic review of physician leadership and emotional intelligence. J Grad Med Educ (2014) 0.86
Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis (2006) 0.86
Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency. Am J Respir Crit Care Med (2003) 0.85
Circulating polymers in α1-antitrypsin deficiency. Eur Respir J (2014) 0.85
Detection of alpha-1 antitrypsin deficiency: a review. Respir Med (2008) 0.85
A review of augmentation therapy for alpha-1 antitrypsin deficiency. Expert Opin Biol Ther (2012) 0.84
Major components of the direct medical costs of alpha1-antitrypsin deficiency. Chest (2003) 0.84
Frequency and causes of combined obstruction and restriction identified in pulmonary function tests in adults. Respir Care (2010) 0.83
Knowledge of alpha-1 antitrypsin deficiency among internal medicine house officers and respiratory therapists: results of a survey. Respir Care (2010) 0.82
The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction. COPD (2012) 0.82
Hemoptysis in a 77-year-old male with a systolic murmur. Chest (2005) 0.82
Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration (2005) 0.81
Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency. Epigenetics (2012) 0.81
Metaphorical medicine: using metaphors to enhance communication with patients who have pulmonary disease. Ann Intern Med (2002) 0.81
Myths and misconceptions about {alpha}1-antitrypsin deficiency. Arch Intern Med (2009) 0.81
Endobronchial hamartoma causing massive hemoptysis. J Bronchology Interv Pulmonol (2009) 0.80
Pulmonary hypertension in lung diseases: survey of beliefs and practice patterns. Respir Med (2010) 0.80
Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia. Chest (2007) 0.80
Estimating FVC from FEV2 and FEV3: assessment of a surrogate spirometric parameter. Chest (2005) 0.80
Cost-effectiveness of population screening for alpha-1 antitrypsin deficiency: a decision analysis. COPD (2005) 0.80
Oxygen therapy in advanced COPD: in whom does it work? Semin Respir Crit Care Med (2010) 0.79
Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options? Expert Opin Pharmacother (2009) 0.79
Augmentation therapy for alpha(1)-antitrypsin deficiency. Drugs (2004) 0.79
Alpha-1 antitrypsin deficiency: an under-recognized but important issue for respiratory therapists. Respir Care (2003) 0.79
A review of the alpha-1 foundation: its formation, impact, and critical success factors. Respir Care (2006) 0.76
The impact on revenue of physician turnover: an assessment model and experience in a large healthcare center. J Med Pract Manage (2006) 0.76
Basilar hyperlucency in a patient with emphysema due to hypocomplementemic urticarial vasculitis syndrome. Respir Care (2003) 0.76
The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency. Am J Respir Crit Care Med (2014) 0.76
An ectopic peripherally inserted central catheter ('ectoPICC'). Cleve Clin J Med (2006) 0.76
The pulmonologist's perspective regarding the solitary pulmonary nodule. Semin Thorac Cardiovasc Surg (2002) 0.75
Quality control for spirometry in large epidemiologic studies: "breathing quality" into our work. Respir Care (2008) 0.75
Rebuttal from Dr Mehta et al. Chest (2015) 0.75
Response. Chest (2015) 0.75
Toward "The Genius of the AND": Balancing Professionalism and Duty Hour Requirements in Graduate Medical Education. J Grad Med Educ (2011) 0.75
Race as an independent prognostic factor in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol (2005) 0.75
Impact of positron emission tomography on clinical decision making. Chest (2006) 0.75
Developing a leadership pipeline: the Cleveland Clinic experience. Perspect Med Educ (2014) 0.75
Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events. 2003. Chest (2009) 0.75
Small cell carcinoma with paraneoplastic polyneuropathy and tumor embolization: a case report and literature review. Respiration (2009) 0.75
The scientific basis for protocol-directed respiratory care. Respir Care (2013) 0.75
Cultural adaptation and reliability analysis of the Modified Dyspnea Index for the Brazilian culture. Rev Lat Am Enfermagem (2010) 0.75
Respiratory care continuing education. Respir Care Clin N Am (2005) 0.75
An analysis of needs for respiratory therapists in northeast Ohio and development of strategies to meet increased recruitment demands. Respir Care (2007) 0.75
Research during fellowship: ten commandments. Chest (2009) 0.75
Biphasic capnogram in a single-lung transplant recipient: a case report. Respir Care (2014) 0.75
On the power and risks of the percent of predicted. Respir Care (2006) 0.75
Introduction to the 50th anniversary of the description of alpha-1 antitrypsin deficiency. COPD (2013) 0.75
Inhaled human insulin: coup or caution? Cleve Clin J Med (2006) 0.75
Women with ulcerating, painful skin lesions. Cleve Clin J Med (2008) 0.75
A computer-aided audit system for respiratory therapy consult evaluations: description of a method and early results. Respir Care (2013) 0.75
A 45-year-old woman with systemic lupus erythematosus and progressive dyspnea. Chest (2007) 0.75
Elastin degradation products as biomarkers in alpha-1 antitrypsin deficiency: lastin' impact? COPD (2013) 0.75
Physician alert suggesting alpha-1 antitrypsin deficiency testing in pulmonary function test (PFT) results. COPD (2009) 0.75
Respiratory therapists' attitudes about participative decision making: relationship between managerial decision-making style and job satisfaction. Respir Care (2004) 0.75